Joint Formulary & PAD

Asenapine - Mania

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Sublingual tablets
Associated Icons :
SPC
Restrictions / Comments :
Important

Asenapine sublingual tablets have been discontinued and should not be initiated in new patients. Supplies of unlicensed asenapine may be available but additional guidance applies to the prescribing of unlicensed and imported medicines. Existing patients should be reviewed and switched where possible, to a suitable licensed alternative.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Asenapine
Indication :
Mania
Group Name :
Keywords :
manic episodes, bipolar disorder
Brand Names Include :
Sycrest
Important Information :

For prescribing by SABP clinicians only.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (0)

  • No records returned.